1 recruiting, 1 suspended, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 1, Suspended 1, Terminated 1 |
Follow Refractory Grade 3a Follicular Lymphoma: new trials by email Literature Review of Refractory Grade 3a Follicular Lymphoma trials Research Report on Refractory Grade 3a Follicular Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma | Phase 2 | Suspended | City of Hope Medical Center | 33 | 2025-03-11 | 2026-01-21 |
| Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma | Phase 2 | Recruiting | City of Hope Medical Center | 41 | 2024-09-09 | 2026-09-22 |
| Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Polatuzumab Vedotin, Rituximab, Rituximab and Hyaluronidase Human - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma | Phase 2 | Terminated | Academic and Community Cancer Research United | 3 | 2021-04-01 | 2024-09-19 |
Lymphoma, Follicular (3) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Mantle-Cell (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1)
Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · polatuzumab vedotin (2) · Biopsy (1) · CT-P10 (1) · Hyaluronoglucosaminidase (1) · Rituximab (1) · tazemetostat (1) · venetoclax (1)
City of Hope Medical Center (2) · Academic and Community Cancer Research United (1)
United States (3)
Catherine S Diefenbach (1) · Matthew Mei, MD (1) · Swetha Kambhampati (1)
P30CA033572 (2), P30CA015083 (1)